Blanket Purchase Agreement HT942523A0016

Award Date 11/1/23
Last Date to Order 10/31/28
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Health Agency (DHA) awarded a $5.3 million single-award Blanket Purchase Agreement (BPA) to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, a foreign-owned, for-profit manufacturer of specialized genomic and proteomic research tools. The BPA, which runs through September 2027, enables DHA to issue firm-fixed-price delivery orders for Biodiscovery's proprietary MYBAITS DNA reagents, custom DNA extraction products, sequencing kits, and other genomic research materials....
The Defense Health Agency awarded Promega Corporation an indefinite delivery vehicle in the form of a blanket purchase agreement valued at up to $11.5 million. The BPA enables the agency to place fixed price calls for DNA analysis equipment, reagents, and related products to support its biomedical research and healthcare programs. Between September 2020 and the present date, the agency has exercised this BPA to award Promega eight calls valued between $816 and $261,323.68 each. The calls require...
This Blanket Purchase Agreement (BPA) contract, awarded by the Defense Health Agency (DHA) to Life Technologies Corporation, provides the agency with a range of scientific instruments, reagents, and consumables to support its healthcare and medical readiness missions. As a prime contractor, Life Technologies leverages its expertise as a manufacturer of specialized biotechnology products, including genetic analyzers, real-time PCR systems, flow cytometry instruments, and sample preparation...
The Defense Health Agency awarded a blanket purchase agreement to Qiagen, LLC for reagents, consumables, and related laboratory supplies. The single award BPA has a potential value of $8 million and a period of performance through February 2025. Two firm fixed price call contracts were subsequently awarded against the BPA, the first for $60,041 worth of reagents and peripherals consumables to be delivered to Bethesda, Maryland by September 2021. The second call contract was for $125,000 of...
The Defense Health Agency (DHA) has awarded a $325,000 Blanket Purchase Agreement (BPA) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The BPA, which runs through February 2029, is for the provision of reagents, equipment, warranty, and license services. Oxford Nanopore Technologies has secured various federal contract awards to supply next-generation genomic sequencing equipment, consumables, and associated services to U.S. government agencies,...
This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA) to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services to the U.S. federal government. The contract has a ceiling value of $5,000,000 and a period of performance through September 16, 2029. Under this BPA, IDT will deliver a variety of custom oligonucleotides, including DNA and RNA, gene fragments, next-generation sequencing products, primers, probes, and...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 (VA-VHA) awarded a single award blanket purchase agreement (BPA) call contract to Life Technologies Corporation to provide pathology and laboratory sequencing reagents. The firm fixed price contract is valued at $1,448,709.34 for the one-year period of performance from July 1, 2023 to June 30, 2024. Life Technologies Corporation, a subsidiary of Thermo Electron Corporation Financial...
The Defense Health Agency awarded a $2.8 million single-award Blanket Purchase Agreement (BPA) to Nanostring Technologies, Inc. to provide custom and commercial off-the-shelf (COTS) assays, panels, and required consumable reagents compatible with Nanostring's nCounter Analysis Systems. This 5-year BPA enables the U.S. Army Research Institute of Infectious Diseases to procure a variety of Nanostring's specialized research products, including custom gene expression panels and reagent kits, to...
The Defense Health Agency has awarded a single-award Blanket Purchase Agreement (BPA) contract to Polyscientific Research and Development Corporation, a leading manufacturer of chemicals, stains, and reagents for in vitro diagnostic testing. The $8 million BPA contract, with a period of performance through September 2026, provides the agency with an efficient mechanism to procure a wide range of reagents and consumable supplies to support its medical testing and research programs. Specific...
The Defense Health Agency (DHA) awarded a $7.5 million single-award Blanket Purchase Agreement (BPA) to One Lambda, Inc., a subsidiary of Thermo Electron Corporation, as a master ordering vehicle for laboratory supplies. This BPA enables streamlined procurement of One Lambda's specialized medical testing reagents, kits, and related products to support ongoing federal healthcare and research initiatives across multiple agencies. Under the BPA, DHA has issued multiple firm-fixed-price delivery...
  • HT942523A0016
    Blanket Purchase Agreement
  • 12
    Federal Contract Awards

The Defense Health Agency (DHA) has awarded a single-award Blanket Purchase Agreement (BPA) valued at $7,433,000 to Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The BPA, awarded in November 2023 with no set-asides, allows DHA to efficiently acquire standardized laboratory supplies, including MiSeq Reagent Kits, ForenSeq Kintelligence Reagents, and other reagents and consumables, to support the agency's ongoing genomic sequencing initiatives. The contract has a period of performance through October 2028 and enables DHA to issue BPA call orders to Verogen for these specialized products, with task orders ranging from $45,483 to $216,803 in ceiling value. The contracted supplies will assist DHA in improving health outcomes for military personnel, veterans, and families through its genomic sequencing programs.

Verogen has extensive experience providing a range of next-generation sequencing products and services to various federal agencies, including the FBI, Army, and NIST, through numerous contract vehicles. The company's ability to deliver these specialized reagents and consumables will help streamline DHA's procurement of laboratory supplies and support the agency's continued efforts in advancing genomic research and improving healthcare for its beneficiaries.

Generated 9/10/24, 9:10 AM